long half-life and large variability [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2020-07-30 10:17 (1337 d 03:22 ago) – Posting: # 21802
Views: 2,425

Hi mrtin,

❝ There are two types of covariates (type 1: continous = subject specfic values; and type 2: categorical variable with a few levels).


Type 2 sounds like the very thing that I would call a fixed factor. :-)

❝ At the first glance a different regulatory pathway might be worth considering based on a PK or exposure similarity evalulation as in such a case there could be more flexibility regarding acceptance of statistical models used to test for equivalence in PK metrics.


❝ Happy to get your thoughts on this idea.


I would always recommend to approach regulators for a discussion. They will always listen but not always agree.

Injectable? Sometimes surface area or body weight is reasonable for exposure modeling. That's a covariate in the word's best sense :-) As in, a continuous variable. If multiple periods or longitudinal study, a covariates like bw may change over time.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,639 registered users;
62 visitors (0 registered, 62 guests [including 2 identified bots]).
Forum time: 12:39 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5